ClinicalTrials.govpublic full text
Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases
autoimmune diseases, refractory autoimmune diseases, cd19 car-t, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 853824
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.